Tau in cerebrospinal fluid: A sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification

Neuroscience Letters

Volumn 418, Issue 2, 2007, Pages 186-189

  Yamamori, Hidenaga ^a   Khatoon, Sabiha ^a   Grundke Iqbal, Inge ^a   Blennow, Kaj ^b   Ewers, Michael ^c   Hampel, Harald ^c   Iqbal, Khalid ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Department of Psychiatry   (Germany)

Author keywords

Cerebrospinal fluid; ELISA; Tau

Indexed keywords

ALZHEIMER DISEASE; ANTIBODY RESPONSE; ARTICLE; BRAIN; CEREBROSPINAL FLUID; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIBODIES; BIOLOGICAL MARKERS; BIOTIN; BRAIN; BRAIN CHEMISTRY; CEREBROSPINAL FLUID PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INDICATORS AND REAGENTS; MALE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TAU PROTEINS; TYRAMINE; UP-REGULATION;

EID: 34247547924     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.03.022     Document Type: Article

References (24)

1. Alonso A.D., Zaidi T., Novak M., Barra H.S., Grundke-Iqbal I., and Iqbal K. Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. J. Biol. Chem. 276 (2001) 37967-37973
2. Arai H., Morikawa Y., Higuchi M., Matsui T., Clark C.M., Miura M., Machida N., Lee V.M., Trojanowski J.Q., and Sasaki H. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem. Biophys. Res. Commun. 236 (1997) 262-264
3. Bensadoun A., and Weinstein D. Assay of proteins in the presence of interfering materials. Anal. Biochem. 70 (1976) 241-250
4. Blennow K., and Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2 (2003) 605-613
5. Blennow K., Wallin A., Agren H., Spenger C., Siegfried J., and Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?. Mol. Chem. Neuropathol. 26 (1995) 231-245
6. Bobrow M.N., Harris T.D., Shaughnessy K.J., and Litt G.J. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J. Immunol. Methods 125 (1989) 279-285
7. Buerger K., Ewers M., Pirttila T., Zinkowski R., Alafuzoff I., Teipel S.J., DeBernardis J., Kerkman D., McCulloch C., Soininen H., and Hampel H. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. Brain 129 (2006) 3035-3041
8. Gomez-Tortosa E., Gonzalo I., Fanjul S., Sainz M.J., Cantarero S., Cemillan C., Yebenes J.G., and del Ser T. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease. Arch. Neurol. 60 (2003) 1218-1222
9. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., and Wisniewski H.M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261 (1986) 6084-6089
10. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., and Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 4913-4917
11. Grundke-Iqbal I., Vorbrodt A.W., Iqbal K., Tung Y.C., Wang G.P., and Wisniewski H.M. Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments. Brain Res. 464 (1988) 43-52
12. Hansen L.A., Masliah E., Galasko D., and Terry R.D. Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa. J. Neuropathol. Exp. Neurol. 52 (1993) 648-654
13. Hulstaert F., Blennow K., Ivanoiu A., Schoonderwaldt H.C., Riemenschneider M., De Deyn P.P., Bancher C., Cras P., Wiltfang J., Mehta P.D., Iqbal K., Pottel H., Vanmechelen E., and Vanderstichele H. Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology 52 (1999) 1555-1562
14. Hu Y.Y., He S.S., Wang X., Duan Q.H., Grundke-Iqbal I., Iqbal K., and Wang J. Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients: an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay. Am. J. Pathol. 160 (2002) 1269-1278
15. Iqbal K., Flory M., Khatoon S., Soininen H., Pirttila T., Lehtovirta M., Alafuzoff I., Blennow K., Andreasen N., Vanmechelen E., and Grundke-Iqbal I. Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers. Ann. Neurol. 58 (2005) 748-757
16. Kanemaru K., Kameda N., Yamanouchi H., and Decreased. CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies. Neurology 54 (2000) 1875-1876
17. Khatoon S., Grundke-Iqbal I., and Iqbal K. Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein. J. Neurochem. 59 (1992) 750-753
18. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
19. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., and Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 (1996) 1113-1124
20. Tapiola T., Overmyer M., Lehtovirta M., Helisalmi S., Ramberg J., Alafuzoff I., Riekkinen Sr. P., and Soininen H. The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease. Neuroreport 8 (1997) 3961-3963
21. Tatebayashi Y., Iqbal K., and Grundke-Iqbal I. Dynamic regulation of expression and phosphorylation of tau by fibroblast growth factor-2 in neural progenitor cells from adult rat hippocampus. J. Neurosci. 19 (1999) 5245-5254
22. Tschampa H.J., Schulz-Schaeffer W., Wiltfang J., Poser S., Otto M., Neumann M., and Kretzschmar H.A. Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies. Neurology 56 (2001) 576
23. Vandermeeren M., Mercken M., Vanmechelen E., Six J., van de Voorde A., Martin J.J., and Cras P. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J. Neurochem. 61 (1993) 1828-1834
24. Vigo-Pelfrey C., Seubert P., Barbour R., Blomquist C., Lee M., Lee D., Coria F., Chang L., Miller B., Lieberburg I., and Schenk D. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology 45 (1995) 788-793